版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認領(lǐng)
文檔簡介
MACS分選與FACS分選10823分鐘,分選1094個小時。而且流式分選需要調(diào)整儀給機器調(diào)節(jié)帶來,而獲取條件不合適,必定會直接影響分選結(jié)果。而MACS分選速度107細胞/1095分鐘時間,大大地提高了工作效率。同時MACS分操作簡單:流式分選需要專門的有豐富經(jīng)驗的操作人員。而MACS分選操作簡單,分選后細胞的:在流式細胞儀分選中,細胞長時間處于高壓液流包裹狀態(tài),加上分選時間長,導(dǎo)致分選后得到的細胞狀態(tài)不好。而MACS分選,由于分選速度快,所需時間短,并且磁珠只有50nm,對細胞無毒性,能最大程度的保留細胞的。裁判員均為同一人的現(xiàn)象,無法真正保證分選結(jié)果的可靠性。而MACS分選后,用流式細回收率:在流式分選中,流式進樣和獲取管道決定了流式分選最高只能獲取80%的總體細胞,加上調(diào)節(jié)儀器條件也會造成細胞損失,因此回收率低。而MACS分選采用批處理方式,能盡可能回收目的細胞?;厥章试?0%以上。分選成本上:流式分選需要的試劑是抗體,每支抗體的平均價格在2000能標記108細胞。而MACS分選需要的磁珠,平均價格在8500左右,但是能分選109細胞。因此MACS分選的成本要遠遠低于FACS分選。(1.CalciumIonophore-TreatedPeripheralBloodMonocytesandDendriticCellsRapidlyDisplayCharacteristicsofActivatedDendriticCells.isolationofmonocytesandimmaturedendriticcells(iDC) fromelutriatedleukapheresatesusingCD14andCD33MicroBeads,VS+columnsandMidiMACSorVarioMACS.AuthorsclaimthatFACSsortingofthecellsimpairedtheirresponsivenesstoionophortreatmentandthustheyusedMACSseparationtocircumventthis.ComparisonofPurityandEnrientofCD34+CellsfromBoneMarrow,UmbilicalCordandPeripheralBlood(PrimedforAphresis)UsingFiveSeparationSystems.EnrientofCD34+cellsusingCD34KitandTheauthorshaveusedFACSsortingandfourofthelabotary-scaledevices(Cellector,Dynabeads,CEPRATE,MiniMACS)whicharebasedonpositiveselectionbyimmunoadsorptiontocompareenrientofCD34+cellsfromdiffrentsamples.Theisolatedcellswereassessedforpurity,yieldandcolonyformingcell(CFC)enrient.MACSshowedcomparablepuritytoFACSandCellectorFlasksBUToutofalltechniquesMACShadhighestyieldandcolonyformingcell-enrient.(3)Proc.Natl.Acad.Sci.USA,1994,91:1323-1327 binationinNormalIgA1+BLymphocytes.HumanBcellsexpressingall-surfaceIgA1werepurifiedfromperipheralblood.AfterFicollgradientcentrifugation,washingtoremoveplaetsandleucinemethylesterlysistodepletemonocytes,lymphocyteswerelabeledwithbiotinylatedanti-IgA1antibody,StreptavidinMicroBeadsandStreptavidin-PE.IgA1+wereenrichedtofrequenciesofupto80%withrecoveriesofupto80%.MACSprovedmuchmoreefficientthanFACSintermsofpurityandrecovery.Theshortprocessingtime(<1h)andlowphysicalforcesrequiredforMACS,comparedtoFACS,alsoresultedinhighercellviability.Tofurtherpurifythecellstohomogenityformolecularysis,MACS-enrichedcellswereprocessedfurtherbyFACS(finalpurity>97%).TheBiologyandApplicationofHumanBoneMarrowStromalCellRecentdataconcerningtheimmunophenotypeandfunctionalcharacteristicsofprecursorcellsfrommarrowstromaltissuewerereviewed.Theauthorscompareddifferentisolationstrategiesofstromalmarrowcells,e.g.FACS,DynalandMACS,andtheypraisedMACStechnologyasthebest:MACSprovidesaparticularlyeffectiveisolationtechniquethatcanbeemployedusingBMmononuclearcellswithoutanypreenrientsteps,reproduciblyproducesexcellentyieldsofSPC,andcanreadilyprocesshighcellStromalcellswereisolatedwithStro1-abandindirectsystem.ForexplicitprotocolseeGronthosandSimmons[No.149].Am.J.Pathol.1996,150:1021-ExpressionPatternandCellularOriginofCytokinesintheNormalandToxoplasmagondii-infectedmurinebrainMACSisolationofCNS-derivedleukocytes:usingeitherdirectCD4orCD8MicroBeadsorindirectlywithF4/80(recognizesmacrophagesandmicroglia)+goatanti-ratMicroBeadsTheauthorsinvestigatedtheintracerebralcytokineproductioninnormalandToxoplasmagondiiinfectedusingimmunohistochemistry,insituhybridization,flowcytometryandRT-PCR.Therefore,theyisolatedCD4+,CD8+Tcellsandmacrophages/microgliacells(F4/80bright/F4/80dim)usingMACStechniquefrombrainofnormalandinfectedmice.TheyfirsttriedtoisolatethesecellswithFACsorting,however,noviablecellscouldberetrievedfrombrainparenchyma...(probably)basedonhighlevelofapoptoticleukocytes...Therefore,amoregentlemethodwhichisMACSwasestablished.Purityoftheisolatedcellpopulationswas>97%,recoveryafter2columnpassageswas~25%.DuetolownumberofCD4+/CD8+TCsinnormalbrain,thesecellscouldonlybeisolatedfrominfectedmice.TheMACSisolationallowedafurthersemitativeRT-PCRforcomparisonofcytokinemRNAindifferentcells.(6)Int.J.Radiat.ImproveddeterminationofvarianterythrocytesattheglycophorinA(GPA)locusandvariantfrequencyinpatientstreatedwithradioiodineforthyroidcancer.ysisoftheGPAgeneasameansforthedeterminationofmutationsduetoe.gradiationsincemutationsaquiredbystemcellsareretainedinerythrocytes.BR6assayissofartheonlyassayusedfortheysisoftheappearanceofredbloodcellvariants.Normallycellsarestainedandysedflowcytometrically.ButtoofewcellscanbeysedthiswaythereforepreenrientwithMACS.HighlyabundantgenesinthetranscriptosomeofhumanandbaboonCD34antigen-positivebonemarrowcells.Usedbiotinylatedanti-CD34antibodies12.8(baboon)orQBEND/10(human)andstreptavidin(SA)beadstopullouthumanandbaboonhematopoeiticstemcellsAuthorsfavorablycomparedMACStoflow"ExpressionstudiesoncDNAarraysrequireafairlylargenumberofcellstoisolateanappropriateamountofRNAforprobepreparation.Becauseofthisconstraint,itwasnecessarytopurifytheCD34+cellsbyimmunomagneticcolumnsratherthanFACS,whichwouldrequireprolongedsorting.ThestressimposedbytheprolongedsortingtimerequiredtopreparethisnumberofcellscandramaticallyreducecellviabilityandyieldofCD34+cellsandmayaltertheirgeneexpressionprofile."分選MACS&More,ApplicationofuMACSStreptavidinMicroBeadsfortheysisofHIV-1directlyfrompatientInthisreport,wenowdescribemarkedimprovementsintheimmunomagneticcaptureprotocolthatpermitsysisofvirionsdirectlyfrompatientsplasmawithoutpriorprocessing.Theimprovedabilityviralcapturetechnologywithoutextensivesampleprocessing,duetotheuniquepropertiesofmMACSMicroBeads,canadvancethistechniqueintonewapplications.Byeliminatingtheneedtoremoveinhibitors(antibodies,acuteserumproteinsetc.)frombiologicfluidsbyprocessing,thiswillallowtheapproachdesscribedheretobeutilizedforbodilyfluidsforwhichextensiveprocessingwouldnotbefeasible(breastmilk,semen,etc.).2:關(guān)于MACS分選后細胞活性的文獻(1)Proc.Natl.Acad.Sci.CD8+TLymphocytesofAfricanGreenMonkeysSecreteanImmunodeficiency-SuppressingLymphokine.TheauthorsinvesitgatedtheinfluenceofCD8TlymphocytesonSIVreplicationinCD4TlymphocytesofAfricangreenmonkey(AGM).TheauthorsusedCD8microbeadsfordepletionofCD8+cellsfromPBMC.AdditionallypositiveselectionofCD4andCD8cellsofAGMswasperformedafterdepletionofmonocytesusingCD14PurityofisolatedTcellfractionswas>98%withviabilityof>EffectofGranulocyte-MacrophageColony-StimulatingFactoronEicosanoidProductionbyMononuclearHumanPBMCwereisolatedfromvenousblood,Ficoll-purified,filteredthroughnylonmeshandthenlabeledwithCD14MicroBeadsandMACSseparatedAuthorsexaminedtheeffectsofGM-CSFonarachidonicacidmetabolisminratalveolarmacrophages,peritonealmacrophagesandMACSisolatedhumanperipheralbloodmonocytes.MacrophagesandmonocyteswereculturedandtreatedwithGM-CSFandtheneicosanoidproductionwasmonitored.TheMACSpurifiedmonocyteswere97%pureandvital(determinedbytrypanblueexclusionatisolationandafterovernightincubation).Preparedcellswerenotactivatedtogenerateeicosanoids.3:MACS分選后細胞功能的文獻(1)J.Immunol.1996,158:637-TheroleofB7-1andLFA-3incostimulationofCD8+isolationofCD4+andCD8+TCfromhumanPBMCusingdirectbeads-- TCfromPBMCafterFicollisolatedusingdirectbeadspurity>98%andCD8>96%cellsusedininvitroassaysligatione.g.withspecificantibodiesauthorsmentionthatMACSsortedcellscanbedirectlyusedforthese'MACSMicroBeadsarebiodegradable posewhencellsare'Theytypicallydonotactivateisolated influencetheirviability,andnobead entisrequired,positivelyisolatedcellscanbeusedimmediaEur.J.ArePrimedCD4+TLymphocytesDifferentfromUnprimedAuthorsinvestigatedthecontributionofantigen-specificTCfrequencytothegenmerationofprimaryandsecondaryCD4+TCresponsesinvitroandinvivo.TheproliferationandIFN-gproductionafterinvitroprimingandrestimulationofnaiveCD45RB+TC(MACSisolated)wasmeasured.MACSpositiveselectionstrategydidnotinfluencenaiveTCfunction!!4:MACS分選后電鏡檢查Leuk.CharacterizationofCD34+HumanHematopoieticProgentitorCellsfromthePeripheralBlood:Enzyme-,Carbohydrate-andImmunocytochemistry,Morphometry,andUltrastructure.CD34+cellswereisolatedusingtheCD34+IsolationKitandCD34+cellswereisolatedusingtheCD34+IsolationKitandMiniMACS(Purity90-95%,Reco
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025年度個人對個人租車合同電子支付范本
- 二零二五年度不銹鋼護欄加工與運輸一體化服務(wù)合同3篇
- 2025年度個人與個人間藝術(shù)品修復(fù)服務(wù)合同4篇
- 2025內(nèi)衣店加盟品牌授權(quán)及區(qū)域管理服務(wù)合同范本
- 二零二五年度大型公共建筑幕墻施工專項合同4篇
- 二零二五年度旅游演藝接待服務(wù)合同范本2篇
- 二零二五年度別墅景觀水體設(shè)計與施工合同272篇
- 二零二五年度醫(yī)院臨床科研合作合同4篇
- 2025年度拌合料生產(chǎn)項目可行性研究與評估合同4篇
- 二零二五年度食品連鎖品牌簡短代理合同范本
- 小王子-英文原版
- 給排水科學(xué)與工程基礎(chǔ)知識單選題100道及答案解析
- 新版中國食物成分表
- 2024年山東省青島市中考生物試題(含答案)
- 河道綜合治理工程技術(shù)投標文件
- 專題24 短文填空 選詞填空 2024年中考英語真題分類匯編
- 再生障礙性貧血課件
- 產(chǎn)后抑郁癥的護理查房
- 2024年江蘇護理職業(yè)學(xué)院高職單招(英語/數(shù)學(xué)/語文)筆試歷年參考題庫含答案解析
- 電能質(zhì)量與安全課件
- 工程項目設(shè)計工作管理方案及設(shè)計優(yōu)化措施
評論
0/150
提交評論